FDx Advisors Inc. Reduces Position in Thermo Fisher Scientific Inc. (TMO)

FDx Advisors Inc. reduced its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 7.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,030 shares of the medical research company’s stock after selling 1,078 shares during the quarter. FDx Advisors Inc.’s holdings in Thermo Fisher Scientific were worth $2,664,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Covington Capital Management raised its holdings in shares of Thermo Fisher Scientific by 0.9% in the 2nd quarter. Covington Capital Management now owns 2,144 shares of the medical research company’s stock worth $374,000 after purchasing an additional 20 shares in the last quarter. Monetary Management Group Inc. raised its holdings in shares of Thermo Fisher Scientific by 0.6% in the 2nd quarter. Monetary Management Group Inc. now owns 12,150 shares of the medical research company’s stock worth $2,120,000 after purchasing an additional 75 shares in the last quarter. Millie Capital Management LLC raised its holdings in shares of Thermo Fisher Scientific by 0.4% in the 2nd quarter. Millie Capital Management LLC now owns 19,149 shares of the medical research company’s stock worth $3,341,000 after purchasing an additional 75 shares in the last quarter. Ropes Wealth Advisors LLC raised its holdings in shares of Thermo Fisher Scientific by 15.8% in the 2nd quarter. Ropes Wealth Advisors LLC now owns 710 shares of the medical research company’s stock worth $124,000 after purchasing an additional 97 shares in the last quarter. Finally, Hall Laurie J Trustee raised its holdings in shares of Thermo Fisher Scientific by 4.6% during the second quarter. Hall Laurie J Trustee now owns 2,851 shares of the medical research company’s stock valued at $497,000 after acquiring an additional 125 shares during the period. Institutional investors and hedge funds own 86.54% of the company’s stock.

Shares of Thermo Fisher Scientific Inc. (TMO) opened at $209.79 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.35 and a quick ratio of 0.92. The company has a market cap of $83,342.88, a P/E ratio of 21.92, a price-to-earnings-growth ratio of 1.52 and a beta of 1.11. Thermo Fisher Scientific Inc. has a 1 year low of $151.74 and a 1 year high of $226.44.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, January 31st. The medical research company reported $2.79 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.66 by $0.13. The company had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $5.72 billion. Thermo Fisher Scientific had a net margin of 10.64% and a return on equity of 16.01%. The company’s revenue for the quarter was up 22.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.41 earnings per share. sell-side analysts predict that Thermo Fisher Scientific Inc. will post 10.81 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, April 16th. Shareholders of record on Thursday, March 15th will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.32%. This is an increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. The ex-dividend date is Wednesday, March 14th. Thermo Fisher Scientific’s payout ratio is currently 10.71%.

A number of equities research analysts have recently issued reports on TMO shares. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “sell” rating to a “hold” rating in a report on Saturday, January 20th. ValuEngine upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. Deutsche Bank set a $226.00 price target on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a report on Thursday, October 26th. Morgan Stanley boosted their price target on shares of Thermo Fisher Scientific from $223.00 to $227.00 and gave the company an “overweight” rating in a report on Thursday, February 1st. Finally, BTIG Research started coverage on shares of Thermo Fisher Scientific in a report on Friday, January 5th. They set a “buy” rating and a $230.00 price target on the stock. Two research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. Thermo Fisher Scientific presently has an average rating of “Buy” and an average price target of $220.50.

In other Thermo Fisher Scientific news, Director William G. Parrett sold 1,000 shares of the business’s stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $209.80, for a total value of $209,800.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Marc N. Casper sold 50,000 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $191.74, for a total transaction of $9,587,000.00. Following the completion of the sale, the chief executive officer now directly owns 302,577 shares of the company’s stock, valued at $58,016,113.98. The disclosure for this sale can be found here. Insiders sold 95,327 shares of company stock valued at $19,470,342 over the last three months. Insiders own 0.49% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “FDx Advisors Inc. Reduces Position in Thermo Fisher Scientific Inc. (TMO)” was first posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright law. The original version of this story can be viewed at https://www.thelincolnianonline.com/2018/02/22/fdx-advisors-inc-reduces-position-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply